| Nizatidine Study (n = 68) | Sibutramine Study (n = 42) | Amantadine Study (n = 48) | Total (N = 158) |
---|---|---|---|---|
Age, years; mean (SD) | 43.5 (10.2) | 38.7 (11.6) | 40.6 (12.0) | 41.3 (11.3) |
Weight, kg; mean (SD) | 85.1 (12.2) | 99.8 (19.7) | 95.1 (18.9) | 92.1 (17.7) |
BMI, kg/m2; mean (SD) | 30.1 (3.8) | 35.0 (5.7) | 32.3 (5.4) | 32.1 (5.2) |
Age at disease onset, years; mean (SD) | 25.5 (7.5) | 23.6 (9.8) | 24.6 (10.6) | 24.7 (9.1) |
BPRS; mean (SD) | 21.0 (14.1)a | 8.3 (6.8) | 11.6 (8.3) | 14.6 (12.1) |
Caucasian race, % | 67.6 | 78.6 | 81.3 | 74.7 |
Gender, % males | 60.3 | 35.7 | 47.9 | 50.0 |
EBA Total; mean (SD) | 11.4 (4.8)b | 19.2 (6.2) | 19.7 (7.9) | 16.0 (7.4) |
VAS (hunger); mean (SD) | 4.2 (2.2)c | 5.7 (2.3) | 6.1 (2.3) | 5.2 (2.4) |
VAS (interest in food); mean (SD) | 4.8 (2.7)c | 5.4 (2.5) | 6.4 (2.9) | 5.4 (2.8) |
VAS (appetite); mean (SD) | 4.9 (2.4)c | 5.9 (2.6) | 6.7 (2.6) | 5.7 (2.6) |
Eating Inventory (cognitive restraint); mean (SD) | 7.1 (4.1)b | 8.1 (3.1) | 7.4 (3.9) | 7.5 (3.8) |
Eating Inventory (disinhibition); mean (SD) | 5.0 (3.0)b | 8.2 (3.8) | 7.4 (3.3) | 6.6 (3.6) |
Eating Inventory (hunger); mean (SD) | 5.2 (2.9)b | 8.4 (3.1) | 8.3 (3.3) | 7.0 (3.4) |